Podcast Episodes

Game-Changing Blood Cancer News at ASCO 2025: Rusfertide Shows Strong Benefit in Polycythemia Vera

Episode 4

A late-breaking abstract presented at the 2025 American Society of Clinical Oncology Annual Meeting (LBA3) showed that rusfertide significantly increased hematocrit control and improved symptoms for …

Published on 3 months ago

Getting Americans to Support Cancer Research May Take a New Message, Oncology Leader Says

Episode 3

When it comes to building support for cancer research in the current environment, “the message that we have had in our field is a good one. But we may need to craft a better message,” says Robert A. …

Published on 3 months ago

“Important Milestone”: Perioperative Durvalumab Improves Event-Free Survival in Gastric Cancer

Episode 2

The addition of perioperative durvalumab in gastric and gastroesophageal junction cancer improved event-free survival, according to findings from the MATTERHORN study. “This trial will be an importan…

Published on 3 months ago

What Does the Biggest News in Breast Cancer From ASCO 2025 Mean for Practice Right Now?

Season 1 Episode 1

Data from the SERENA-6 trial, presented at the 2025 American Society of Clinical Oncology Annual Meeting, have the potential to dramatically change advanced estrogen receptor–positive, HER2-negative …

Published on 3 months, 1 week ago

Practice-Changing “Inflection Point” Coming in ESR1-Positive Breast Cancer Care?

Editor’s Note: This interview was recorded shortly before the 2025 American Society of Clinical Oncology Annual Meeting.

Big questions associated with ESR1 mutations in patients with hormone recepto…

Published on 3 months, 3 weeks ago

When ESR1 Mutations Arise in Breast Cancer Patients With PIK3CA Mutations: What Next?

The approach to ESR1 and PIK3CA mutations in patients with hormone receptor–positive metastatic breast cancer continues to evolve. What role does circulating tumor DNA (ctDNA) play in treatment decis…

Published on 4 months, 2 weeks ago

How “Remarkable Change” in EGFR-Mutated NSCLC Care Is Making a Difference for Patients

The last few years have seen “a remarkable change in both our approach and management of EGFR lung cancer,” says Shirish M. Gadgeel, MD, division head for hematology/oncology and associate director o…

Published on 5 months ago

Oncologists Urged to Discuss Fertility With Patients, as ASCO Updates Guidelines

When it comes to tackling fertility issues associated with cancer, “oncology clinicians are often reluctant to talk about this because it is really not our wheelhouse,” says Alison Wakoff Loren, MD, …

Published on 5 months ago

“Second-Line ER-Positive Breast Cancer Has Just Become Very Complicated”

“Second-line [estrogen receptor (ER)]-positive breast cancer has just become very complicated,” says Erika P. Hamilton, MD, the director of breast cancer and gynecologic cancer research at Sarah Cann…

Published on 5 months, 1 week ago

Will Generational Divide Among Oncologists Affect How AI Changes Cancer Care?

Burnout among oncologists is a serious concern, and artificial intelligence (AI) represents a potential solution, says Debra Patt, MD, PhD, MBA, a practicing oncologist and breast cancer specialist i…

Published on 5 months, 2 weeks ago